The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial. (2018)
Attributed to:
AMBROSIAC - A Menu for Brain Responses Opposing Stress-Induced Alterations in Cognition
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2215-0366(18)30345-6
PubMed Identifier: 30322824
Publication URI: http://europepmc.org/abstract/MED/30322824
Type: Journal Article/Review
Volume: 5
Parent Publication: The lancet. Psychiatry
Issue: 11
ISSN: 2215-0366